GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nipro Corp (OTCPK:NPRRF) » Definitions » Cash Flow for Lease Financing

Nipro (NPRRF) Cash Flow for Lease Financing : $0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Nipro Cash Flow for Lease Financing?

Nipro's Cash Flow for Lease Financing for the three months ended in Dec. 2023 was $0 Mil. Nipro's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was $0 Mil.

Compared with last quarter ($0 Mil in Sep. 2023 ), Nipro's Cash Flow for Lease Financing remained the same in Dec. 2023 ($0 Mil).


Nipro Cash Flow for Lease Financing Historical Data

The historical data trend for Nipro's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nipro Cash Flow for Lease Financing Chart

Nipro Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.72 -27.34 -38.31 -28.80 -22.43

Nipro Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nipro Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nipro Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Nipro's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Nipro (NPRRF) Business Description

Traded in Other Exchanges
Address
3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Nipro (NPRRF) Headlines

No Headlines